Filtered By:
Condition: Ischemic Stroke
Cancer: Cancer

This page shows you your search results in order of relevance. This is page number 4.

Order by Relevance | Date

Total 1713 results found since Jan 2013.

Antithrombotic Therapy Strategy for Cancer-Associated Ischemic Stroke: A Case Series of 26 Patients
The risk of complications from thromboembolism is increased for patients with malignancy. Cancer-associated stroke is also a serious issue with regard to the management of patients with cancer because stroke incidence often causes disabilities that affect daily life and cancer treatment strategy.
Source: Journal of Stroke and Cerebrovascular Diseases - May 17, 2018 Category: Neurology Authors: Hiroyuki Naito, Tomohisa Nezu, Naohisa Hosomi, Shiro Aoki, Hiroki Ueno, Kazuhide Ochi, Hirofumi Maruyama Tags: Case Studies Source Type: research

Temporal Trends in the Use of Acute Recanalization Therapies for Ischemic Stroke in Patients with Cancer
Objective: We sought to characterize the US nationwide temporal trends in recanalization therapy utilization for ischemic stroke among patients with and without cancer. Methods: We identified all acute ischemic stroke (AIS) hospitalizations in the National Inpatient Sample from January 1, 1998 to September 30, 2015. The primary exposure was solid or hematologic cancer. The primary outcome was use of intravenous thrombolysis. The secondary outcome was use of endovascular therapy (EVT). Results: Among 9,508,804 AIS hospitalizations, 503,510 (5.3%) involved cancer patients.
Source: Journal of Stroke and Cerebrovascular Diseases - May 28, 2019 Category: Neurology Authors: Abhinaba Chatterjee, Alexander E. Merkler, Santosh B. Murthy, Jaclyn E. Burch, Monica L. Chen, Gino Gialdini, Hooman Kamel, Karla V. Ballman, Babak B. Navi Source Type: research

Early Prediction of One-Year Mortality in Ischemic and Haemorrhagic Stroke
The worldwide stroke incidence is 17 million per year,1 and 12 % of all deaths worldwide are caused by stroke making it the third leading cause of death after cancer and ischemic heart disease.2
Source: Journal of Stroke and Cerebrovascular Diseases - February 6, 2020 Category: Neurology Authors: Jacob Liljehult, Thomas Christensen, Karl Bang Christensen Source Type: research

Low Serum Eicosapentaenoic Acid Levels in Cryptogenic Stroke with Active Cancer
Since Armand Trousseau first described migratory superficial thrombophlebitis in 1865, patients with malignant cancer have been known to be in a hypercoagulable state and at risk for the development of cancer-associated thrombosis.1 Approximately 7% of cancer patients have symptomatic cerebrovascular diseases during the clinical course of cancer, and 15% have cerebrovascular lesions at autopsy.2 Previous studies have demonstrated that cancer patients with cryptogenic ischemic stroke often have high serum D-dimer levels and multiple vascular lesions and show cryptogenic stroke etiology, which seems to be due to a hypercoagulable state.
Source: Journal of Stroke and Cerebrovascular Diseases - May 14, 2020 Category: Neurology Authors: Tesseki Izumi, Hitoki Nanaura, Naohiko Iguchi, Maki Ozaki, Kazuma Sugie Source Type: research

D-dimer and Body CT to Identify Occult Malignancy in Acute Ischemic Stroke
Patients with acute ischemic stroke associated with cancer have D-dimer elevations greater than those with acute ischemic stroke or cancer alone. While D-dimer has been proposed as a screening tool to identify such patients, its use in clinical practice to identify malignancy and to inform the use of CT scanning has not been well characterized.
Source: Journal of Stroke and Cerebrovascular Diseases - October 8, 2020 Category: Neurology Authors: Jon Rosenberg, David Do, Brett Cucchiara, Steven R. Mess é Source Type: research

Reperfusion Therapy in Acute Ischemic Stroke with Active Cancer: A Meta-Analysis Aided by Machine Learning
While the prevalence of active cancer patients experiencing acute stroke is increasing, the effects of active cancer on reperfusion therapy outcomes are inconclusive. Thus, we aimed to compare the safety and outcomes of reperfusion therapy in acute stroke patients with and without active cancer.
Source: Journal of Stroke and Cerebrovascular Diseases - March 26, 2021 Category: Neurology Authors: Mi-Yeon Eun, Eun-Tae Jeon, Kwon-Duk Seo, Dongwhane Lee, Jin-Man Jung Source Type: research

Prevalence and Predictors of Multivitamin Supplement Use After Stroke in Ghana
Multivitamin supplementation is widely practiced in high-income countries due to a popular belief of its health promotion and disease prevention benefits. Evidence for their purported efficacy has been mixed. Regarding the efficacy of multivitamins on prevention of cardiovascular disease, cancer, or all-cause mortality, some studies have shown no effect,1 –4 harmful effects,5,6 and beneficial effects.7,8 Three prospective studies have evaluated the effect of multivitamin use on stroke prevention with two showing negative outcomes3,5 and the third among 72,000 Japanese showing frequent use of multivitamins was associated ...
Source: Journal of Stroke and Cerebrovascular Diseases - March 18, 2021 Category: Neurology Authors: Fred Stephen Sarfo, Bruce Ovbiagele Source Type: research

Endovascular thrombectomy for acute ischemic stroke in patients with cancer: a propensity-matched analysis
Conclusions In propensity matched analysis of patients undergoing EVT for AIS with and without cancer, 90-day functional outcomes and mortality were similar. However, there was a significantly higher rate of HT in cancer patients.
Source: Journal of NeuroInterventional Surgery - November 14, 2022 Category: Neurosurgery Authors: Joshi, K. C., Grewal, P., Beer-Furlan, A., Vargas, A., Osteraas, N., Dafer, R., Chen, M. Tags: Editor''s choice, Ischemic stroke Source Type: research

Clinical features and prognostic factors in patients with cancer-associated multiple ischemic stroke: A retrospective observational study
Cancer causes coagulation abnormalities in arterial and venous systems.1,2 A highly active cancer is an established risk factor of ischemic stroke,3 and patients with cancer sometimes receive additional burden due to cancer-associated ischemic stroke (CAIS).4,5 Multiple cerebral infarctions involving various cerebrovascular territories in cryptogenic CAIS, referred to as “multiple CAIS” in this report, are of particular clinical interest since they lead to poor prognosis, with a median survival of at most a few months.
Source: Journal of Stroke and Cerebrovascular Diseases - October 21, 2022 Category: Neurology Authors: Jun Tanimura, Tomokiyo Yamamoto, Takao Hashimoto Source Type: research

Quality-of-life, concerns, and treatment priorities in patients with cancer-related ischemic stroke: A prospective survey study
Comorbid cancer with stroke is a complex situation with multiple factors affecting quality of life (QoL). No specific questionnaire exists to assess current drivers of QoL and future concerns and priorities in patients with cancer-related stroke.
Source: Journal of Stroke and Cerebrovascular Diseases - August 2, 2023 Category: Neurology Authors: Judy Dawod, Mohammad Hossein Abbasi, Babak B. Navi, Scott E. Kasner Source Type: research

Recurrent Ischemic Stroke in a Patient with the Trousseau Syndrome Treated with Dabigatran
A 70-year-old man with multiple ischemic strokes was diagnosed with cardiac embolism and treated with dabigatran. Three months later, he suddenly developed vertigo and vomiting. Magnetic resonance imaging, showed recurrent lesions and blood tests revealed hypercoagulability, hypoproteinemia, and elevated cytokeratin 19 fragments that serve as a tumor marker of lung cancer. Chest computed tomography showed there were small nodules in bilateral lungs and swollen mediastinal lymph nodes. A conclusive diagnosis was impossible because the patient declined invasive procedures. We suspected primary lung cancer and diagnosed conco...
Source: Journal of Stroke and Cerebrovascular Diseases - February 21, 2014 Category: Neurology Authors: Kosuke Yoshida, Takashi Kimura, Yoko Aburakawa, Yasuhiro Suzuki, Kenji Kuroda, Osamu Yahara Tags: Case Reports Source Type: research

Fatal Intracranial Hemorrhage after Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Associated with Cancer-related Nonbacterial Thrombotic Endocarditis
Nonbacterial thrombotic endocarditis (NBTE) is associated with hypercoagulability in patients with inflammatory states such as cancer and autoimmune diseases. Cardiac vegetations caused by NBTE often lead to life-threatening systemic thromboembolism that most frequently affects the brain, spleen, and kidneys. A 54-year-old woman diagnosed with ovarian cancer suddenly developed back pain and left hemiparesis. Although intravenous alteplase (rt-PA) therapy was administered to treat hyperacute ischemic infarction detected by magnetic resonance imaging, intracranial hemorrhage occurred in the left hemisphere several hours late...
Source: Journal of Stroke and Cerebrovascular Diseases - August 11, 2014 Category: Neurology Authors: Takuya Yagi, Kie Takahashi, Mariko Tanikawa, Morinobu Seki, Takato Abe, Norihiro Suzuki Tags: Case Reports Source Type: research

Predictors of Occult Cancer in Acute Ischemic Stroke Patients
We investigated the prevalence of occult malignancy (OM) in acute ischemic stroke patients to evaluate if any biological marker could help to detect the presence of OM.
Source: Journal of Stroke and Cerebrovascular Diseases - April 13, 2015 Category: Neurology Authors: Dolores Cocho, Jordi Gendre, Anuncia Boltes, Jordi Espinosa, Ana C. Ricciardi, Jordi Pons, Marta Jimenez, Pilar Otermin Source Type: research

Warfarin-Resistant Deep Vein Thrombosis during the Treatment of Acute Ischemic Stroke in Lung Adenocarcinoma
A 66-year-old man with acute ischemic stroke in the setting of lung adenocarcinoma developed acute-onset deep vein thrombosis (DVT) of the lower limbs after changing to warfarin from a heparin combination. The diagnosis of warfarin-resistant DVT was established based on the laboratory data and clinical evaluation. Heparin administration resulted in good control of thrombin regulation. Cancer patients are at high risk of venous thromboembolism, and the combination of these 2 conditions is known as Trousseau's syndrome.
Source: Journal of Stroke and Cerebrovascular Diseases - June 21, 2016 Category: Neurology Authors: Hiroyuki Naito, Shiro Aoki, Naoko Sumi, Kazuhide Ochi, Naohisa Hosomi, Hirofumi Maruyama, Masayasu Matsumoto Tags: Case Studies Source Type: research